Vedanta Biosciences Initiates Phase 2 Study for Lead Rationally-Defined Bacterial Consortium Product Candidate, VE303

Press/Media

Period	17 Dec 2018

Media coverage

Title	Vedanta Biosciences Initiates Phase 2 Study for Lead Rationally-Defined Bacterial Consortium Product Candidate, VE303
Media name/outlet	Pharmacy Choice
Country/Territory	United States
Date	17/12/18
URL	www.pharmacychoice.com/news/article.cfm?Article_ID=2155398
Persons	Jeremiah Faith